BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 17, 2004
View Archived Issues
Genzyme's Fine Related To Cerezyme Reduced To £3M
Read More
From Services To Cancer: Semafore's Focus Change
Read More
Other News To Note
Read More
GTC Publicly Raising $15M To Support ATryn Progress
GTC Biotherapeutics Inc. expects to raise $15 million by selling 6.4 million shares of its common stock at $2.34 per share. (BioWorld Today)
Read More
ZymoGenetics' North American IL-20 Rights Licensed To Novo
Read More